A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

计划入组 91 人 · 首次发布于 2010 年 7 月 16 日

VisAR Augmented Reality Navigation of Ventriculostomy

计划入组 50 人 · 首次发布于 2023 年 11 月 15 日

VITARIA Registry Study

计划入组 200 人 · 首次发布于 2015 年 9 月 10 日

VISTA Agonist

VISTA-Ig

12-MTA (Viswa)

ISARNA THERAPEUTICS

United States

VICARI STEFANO

Italy

Cidara Therapeutics

United States

NovaBridge Subsidiary Visara Assigns VIS-101 License to Everest Medicines for Asian Markets

NovaBridge's VIS-101 Shows Promising Phase 2a Results in Wet AMD with Potential Best-in-Class Durability

I-Mab Announces Strategic Transformation to NovaBridge Biosciences with Hong Kong IPO Plans and VIS-101 Acquisition